Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
One or more suppliers on this contract have also made political donations. See supplier details below.
Project title: NHS National Framework for Omalizumab commencing 1st February 2026
Offer reference number: CM/TNS/25/5734
Period of framework: 1 February 2026 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| CELLTRION HEALTHCARE UNITED KINGDOM LIMITED | 11685363 | ~£173,218,000 estimated from lot values | 1 lot Lot 1 | - |
| MERCURY PHARMACEUTICALS LIMITED | 02619880 | ~£173,218,000 estimated from lot values | 1 lot Lot 1 | - |
| NOVARTIS PHARMACEUTICALS UK LIMITED | 00119006 | ~£173,218,000 estimated from lot values | 1 lot Lot 1 | DONOR£3K across 2 donations To: Mr Nicholas Palmer LOBBYIST M&F Health (7 quarters) Sovereign Strategy Limited (1 quarter) MP LINK Mr David Lammy— Employment and earnings |
This procurement was divided into 1 lots, each awarded separately. 3 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Feb 2026 – Aug 2027 | £85,785,000 £87,433,000 initial term | 3 | active |
Notices published under the Procurement Act 2023 name every bidder, including unsuccessful ones.
| Bidder | Bid on | Outcome |
|---|---|---|
| CELLTRION HEALTHCARE UNITED KINGDOM LIMITED | Lot 1 | Won |
| MERCURY PHARMACEUTICALS LIMITED | Lot 1 | Won |
| NOVARTIS PHARMACEUTICALS UK LIMITED | Lot 1 | Won |
Weightings from the notice.
Government spending data: These suppliers have received £169,787,630 in 1,452 payments (over £25k) from Manchester University NHS Foundation Trust, NHS England, Guy's and St Thomas' NHS FT, Maidstone and Tunbridge Wells NHS Trust, East Sussex Healthcare NHS Trust and 9 more public bodies (2018-04-10 to 2026-03-23).